INTRODUCTION
The consensus octamer motif 5h-ATGCAAAT-3h, which is present in the promoters of genes displaying a widespread as well as a tissue-specific expression pattern, is a recognition site of the ubiquitously expressed Oct-1 [1, 2] and the B-cell-restricted Oct-2 [3] [4] [5] transcription factors. These two proteins belong to the POU family of transcription factors, including additionally the mammalian Pit-1 factor and the developmental control protein unc86 of Caenorhabditis elegans, hence the name of this group (Pit, Oct, Unc). All these factors share the conserved POU domain of approx. 160 amino acids in length, consisting of an Nterminal POU-specific sequence and a homeodomain that is closely related to other homeobox proteins. Both subdomains are connected by a short variable linker sequence. The entire POU domain is required for sequence-specific DNA binding and also mediates protein-protein interactions (for reviews see [6] [7] [8] ).
Regulation of gene expression by post-translational modifications of transcription factors is a commonly observed mechanism. Phosphorylation and dephosphorylation of transcription factors are the most frequently used mechanisms, which regulate their activity in response to different extra-and intracellular signals and enable convergence of different signalling pathways at the same factor. Phosphorylation may cause diverse effects on transcription factor activity and affect translocation to the nucleus, DNA binding or interaction of a transcription factor with the basal transcription apparatus (reviewed in [9, 10] ). Activities of several members of the POU-domain factors' family were shown to be modulated by this mechanism. Oct-1 is hyperphosphorylated as cells enter mitosis and this correlates with a strongly reduced binding of this factor to the octamer site and a concomitant inhibition of transcription. Phosphorylation by phosphorylation of this factor, a strong reduction of Oct-2 binding to the octamer site from the murine BLR1 promoter was observed. This finding correlates well with the down-regulation of expression of the BLR1 gene in murine splenic cells but not in lymphoid cells of human origin treated with okadaic acid. These data support the hypothesis that phosphorylation of Oct-2 may be a mechanism by which activities of the promoters containing non-canonical octamer sequences are differentially regulated in response to extracellular stimuli.
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of Oct-1 is rapidly reversed as cells exit mitosis and enter the G " phase of the cell cycle [11, 12] . It was shown that mitosis-specific phosphorylation of a single serine residue located in the homeodomain of Oct-1 by cAMP-dependent protein kinase A was sufficient to inhibit DNA-binding ability of this factor [13] . Another member of the POU-domain family, Pit-1, was shown to become phosphorylated in pituitary cells at two distinct sites in the homeodomain in response to phorbol esters and cAMP [14] .
Although there are many indications that changes of the phosphorylation status of the POU-domain proteins modulate their ability to activate transcription, very little is known about the role phosphorylation plays in the transcriptional potential of the Oct-2 factor. Initial observations indicated that Oct-2 is phosphorylated in i o and suggested that this factor becomes more competent to activate transcription in the phosphorylated state [15] . However, the location of the sites of phosphorylation in the Oct-2 factor were not identified in this study. Based on the observed increase in the activation potential of the phosphorylated Oct-2 it was suggested that phosphorylation causes conformational changes of the protein that either create a new or unmask an existing activation domain. In another study the effects of different kinases and inhibitors of phosphatases on the DNA binding of nuclear Oct-2 were investigated in itro [16] . This study revealed that both tested kinase activities and inhibition of cellular phosphatases modulated Oct-2 DNA binding in a binding-site-dependent mode. In particular, inhibition in itro of protein phosphatase 1 (PP1) and PP2A present in Daudi cell nuclear extracts by okadaic acid produced no effect on the Oct-2 binding to the TAATGARAT motif from Herpes simplex virus immediate early 4\5 genes. At the same time okadaic acid added to the nuclear extracts effectively inhibited binding of Oct-2 to the classical octamer sequence derived from the histone 2B gene promoter [16] . Therefore, this study [16] indicated that phosphorylation could represent a specific mechanism whereby Oct-2 binding to low-affinity DNA binding sites would be regulated independently of high-affinity sites.
BLR1\CXCR5 (Burkitts ' lymphoma receptor 1\CXC-chemokine receptor 5) is a lymphoid-specific chemokine receptor that directs migration of lymphocytes within specific compartments of the immune system [17, 18] . Expression of the receptor BLR1 is restricted to mature resting B cells and to a subpopulation of T-helper cells [19] . The promoter sequences of the human and murine BLR1 genes are highly homologous and the identified binding sites are almost identical in both promoters [20, 21] . We demonstrated previously that the expression of the BLR1 gene is regulated in both humans and mice in an Oct-2 factor-dependent mode. The non-canonical octamer motif located downstream of the transcription start site was identified as the most essential promoter element, which mediates activation of the promoter by Oct-2 in both species. A mutation that effectively blocked binding of octamer factors to this site resulted in a complete inactivation of the promoter activity [20] . In the present study we compared the ability of hyperphosphorylated Oct-2 to bind to the octamer motif 5h-AAGCAAAT-3h of the human BLR1 promoter sequence and to the motif 5h-AAACAAAT-3h of the murine sequence. We show that phosphorylation of this factor in i o results in a selective down-regulation of its binding to the low-affinity octamer sequence of the murine but not of the human BLR1 promoter. This observation was found to correlate with the abrogation of the BLR1 gene expression in murine cells, suggesting that phosphorylation of Oct-2 may exert profound effects on BLR1 expression in mice.
MATERIALS AND METHODS

Cell culture, transient transfection and reporter assay
The single-cell suspensions of mononuclear cells from human tonsils or murine spleens were obtained by disruption of the freshly harvested organs through a fine stainless steel sieve into ice-cold PBS supplemented with 3 % fetal calf serum. The red blood cells were depleted from the suspension by lysis in hypotonic ammonium chloride solution. The primary cell cultures as well as the haematopoietic cell lines (Raji, Namalwa, Abl\Oct2-ER) were cultivated in RPMI 1640 medium supplemented with 10 % (v\v) fetal calf serum at 37 mC with 5 % CO # . The exponentially growing cells were transfected by electroporation (1070 µF and 250-300 V) with 20-40 µg of plasmid DNA, harvested 24 h after transfection and lysed with reporter lysis buffer (Promega, Madison, WI, U.S.A.). Luciferase activity was determined in an LB 9501 luminometer (EGjG Berthold, Bad Wildbad, Germany) using a luciferase assay system (Promega).
Plasmid constructs and site-directed mutagenesis
The pOEV1 vector expressing human Oct-2 was kindly provided by W. Schaffner (University of Zurich, Zurich, Switzerland). The constructs expressing mutated Oct-2 protein were generated by PCR-based site-directed mutagenesis of the fragment corresponding to the open reading frame of Oct-2 with subsequent cloning into the pcDNA3.1 vector (Invitrogen, Carlsbad, CA, U.S.A.). The construct blr1MH-Luc was generated using the QuikChange4 site-directed mutagenesis kit (Stratagene, La Jolla, CA, U.S.A.). All mutated constructs were controlled by sequencing. To generate the pGEX-Oct2 construct, the Oct-2 open-reading-frame fragment was cloned in the pGEX-2T vector (Pharmacia, Piscataway, NJ, U.S.A.) in frame with the coding region of the glutathione S-transferase (GST) domain.
Preparation of protein extracts
Nuclear extracts from Raji cells were prepared as described by Schreiber et al. [22] . To prepare whole-cell extracts, 10'-10( harvested cells were washed with an ice-cold buffered saline solution, collected by centrifugation and resuspended in 50-200 µl of an ice-cold high-salt buffer [20 mM Hepes (pH 7.9), 0.35 M NaCl, 1 mM MgCl # , 0.2 mM EDTA, 0.1 mM EGTA, 1 % Nonidet P-40, 20 % glycerol, 1 mM dithiothreitol (DTT), 5 µg\ml aprotinin, 5 µg\ml leupeptin, 5 µg\ml pepstatin A]. The suspension was vigorously vortexed for 30 s and was shaken for 20 min at 4 mC on a shaking platform. The extract was cleared by centrifugation (13 800 g at 4 mC for 5 min) and protein concentrations were determined by the Bradford method (Bio-Rad Laboratories GmbH, Munich, Germany). The extracts were either used for further analysis immediately after preparation or aliquotted and stored at k80 mC.
Electrophoretic mobility shift assays (EMSAs)
EMSAs were performed with the double-stranded oligonucleotides labelled by filling in the overhangs with Taq polymerase (Gibco-BRL) in the presence of radioactive dNTPs at 54 mC. The sequences of the oligonucleotides used (top strand only) were as follows : mur-Oct 5h-GGATGGCTC-ATTTGTTTAAGTT ; hum-Oct 5h-GGAGCTCATTTGCTT-AAA ; and Oct-wt 5h-GGCAGAAAGCTCATTTGCATTA-AGACC (where the underlined sequence indicates the octamerbinding site).
Approx. 5-10 µg of nuclear or whole-cell extracts was incubated with 30 fmol of labelled oligonucleotides in a binding buffer [10 mM Hepes (pH 7.9), 0.1 M KCl, 1 mM EDTA, 1 mM DTT, 4 % ficoll] containing 50 µg\ml double-stranded poly(dIdC) (Pharmacia Biotech, Uppsala, Sweden) for 15 min at room temperature. Subsequently the reaction mixtures were separated in a 5 % (w\v) polyacrylamide gel in 0.5iTBE (Tris\ borate\EDTA) buffer. After electrophoresis the gel was dried and autoradiographed. Alternatively the retarded complexes were visualized with Fuji BAS 1000 bioimaging plates for quantification of the results.
Western-blot analysis
Probes of nuclear or whole-cell extracts containing 20 µg of protein were heated at 95 mC for 5 min and resolved by electrophoresis through SDS\polyacrylamide (10 %) gels [23] . Proteins were electrophoretically transferred on to nitrocellulose (Hybond-C, Amersham) and immunoblotting was performed in TBST [10 mM Tris\HCl (pH 8.0), 150 mM NaCl and 0.05 % Tween 20]\5 % non-fat dry milk powder using the rabbit polyclonal anti-(human Oct-2) antibody (Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.) at 0.1 µg\ml and alkaline phosphatase-conjugated secondary antibody (Sigma) at 1 : 2000 dilution. Immunoreactive proteins were visualized with the chromogenic reaction substrate NBT\BCIP (Nitro Blue Tetrazolium\5-bromo-4-chloroindol-3-yl phosphate ; Promega).
RNA isolation, Northern blotting and hybridization
Total RNA was prepared with the TRIzol reagent (Gibco-BRL) according to the supplied protocol. Total RNA (30 µg per lane) Phosphorylation-induced down-regulation of Oct-2 DNA binding was resolved through a denaturing 1.2 % agarose gel and transferred on to a nylon membrane (Hybond-N, Amersham) according to the previously described procedure [24] . For hybridization the filter was incubated for 2 h at 68 mC with hybridization buffer [0.5 M Na # HPO % (pH 7.2), 7 % SDS, 1 mM EDTA and 1 % BSA] after which the radiolabelled probe was added and the filter incubated at 68 mC for 24 h. The filter was washed with 2iSSC\0.1 % SDS (where 1iSSC is 0.15 M NaCl\0.015 M sodium citrate) twice for 20 min at room temperature followed by stringent washing steps with 0.2iSSC\ 0.1 % SDS at 55 mC. The blot was exposed to PhosphoImaging plates and the image read with the bioimaging analyser (Fujix BAS 2000). The absorbances of the bands were determined using the bioimaging analysis software (MacBas).
Expression and phosphorylation in vitro of the recombinant Oct-2 protein
Escherichia coli were transformed with the construct pGEX-Oct2 and induced with isopropyl β--thiogalactoside according to the standard protocol. Cells were harvested and subjected to Frenchpress lysis in suspension buffer (150 mM NaCl, 16 mM Na # HPO % , 4 mM NaH # PO % and 1 % Triton X-100). The cleared lysate was applied to a column of glutathione-agarose. The column was washed extensively with the suspension buffer after which the matrix particles with the bound GST fusion proteins were washed and resuspended in 50 mM Tris\HCl (pH 8.0).
Phosphorylation in itro of the bound proteins was performed with crude Raji cell lysates. Exponentially growing cells were treated for 2 h with 100 ng\ml okadaic acid (Alexis Corporation, La$ ufelfingen, Switzerland) and resuspended in ice-cold lysis buffer [20 mM Tris\acetate (pH 7.0), 0.1 mM EDTA, 1 mM EGTA, 1 mM Na $ VO % , 10 mM β-glycerophosphate, 50 mM NaF, 5 mM pyrophosphate, 1 % Triton X-100, 0.27 M sucrose, 2 mM DTT, 5 µg\ml aprotinin, 5 µg\ml pepstatin A, 5 µg\ml leupeptin and 100 ng\ml okadaic acid] at a concentration of 10' cells per 100 µl. The suspension was vortexed vigorously for 30 s, incubated on ice and clarified by centrifugation (13800 g at 4 mC for 5 min). The suspension of agarose matrix with the bound fusion proteins was mixed with 100-200 µg of the cell lysate in the reaction buffer (50 mM sodium β-glycerophosphate, 0.1 mM EDTA, 4 mM magnesium acetate and 0.1 mM ATP) containing 5 µCi of [γ-$#P]dATP (NEN Life Science Products, Bad Homburg, Germany) per reaction. The reaction mix was incubated at 30 mC for 1 h. The agarose matrix was precipitated by brief centrifugation at 320 g and washed 5-8 times in suspension buffer. After the final washing step the GST fusion proteins were eluted from agarose into Laemmli loading buffer by heating at 95 mC for 5 min. The proteins were separated in a SDS\ polyacrylamide (10 %) gel. After the electrophoretic separation the gel was dried and exposed to a Fuji BAS 1000 bioimaging plate for visualization of labelled proteins.
Proteolytic phosphopeptide analysis of Oct-2 protein
Gel bands producing the strongest radioactive signal were excised from the gel with a scalpel, cut into small gel cubes, washed extensively in 0.1 M Tris\acetonitrile (1 : 1, v\v) and dried under vacuum. After reduction and alkylation in situ by iodoacetamide, proteolytic digestion of gel-immobilized proteins was performed overnight at 37 mC with either 0.5 µg of trypsin or 1 µg of chymotrypsin (Boehringer Mannheim, Mannheim, Germany) in 150 µl of 0.1 M Tris\HCl buffer (pH 8.1). The peptides were recovered from the gel pieces by 3-fold extraction with a mixture of 60 % acetonitrile\0.1 % trifluoroacetic acid at 30 mC for 20 min. After reducing the volume of eluent to approx. onequarter in a Speed Vac, the eluted peptides were fractionated by reverse-phase HPLC, applying the mixture to a µRPC C # \ C ) SC2.1\10 narrow-bore column from the SMART4 system (100i2.1 mm ; LKB Pharmacia, Uppsala, Sweden). The petides were eluted with 0.1 % trifluoroacetic acid buffer using a gradient of increasing concentration of acetonitrile (5-50 %). Approx. 80 fractions were collected automatically and subjected to Cerenkov radioactivity counting (LS 6000LL, Beckman Instruments) in duplicate measurements. Peptide identification of fractions that produced a radioactive signal significantly exceeding the background level was performed with a Procise Protein Microsequencer (Applied Biosystems, Foster City, CA, U.S.A.). In some cases peptide size was determined by MS (Q-tof, Micromass, Manchester, U.K.).
RESULTS
Okadaic acid induces hyperphosphorylation of cellular Oct-2 on serine and/or threonine residues
To investigate the effect of phosphorylation of Oct-2 on the functional activity of this factor we incubated Raji cells for 2 h at 37 mC with 100 ng\ml (0.125 µM) okadaic acid. This substance is a strong tumour promoter that acts by inhibiting the cellular serine\threonine-specific PPs PP1 and PP2A and by inducing phosphorylation of numerous cellular proteins [25] . The nuclear extracts from cells stimulated by okadaic acid as well as from unstimulated cells containing equal amounts of protein were analysed by immunoblotting using a polyclonal Oct-2-specific antibody. In unstimulated cells ( Figure 1A , lane 1) Oct-2 is represented by a heterogeneous array of species characterized by different mobilities in SDS\PAGE. Inhibition of cellular phosphatases by okadaic acid results in a decrease of the electrophoretic mobility of all species ( Figure 1A, lane 2) . The observed effect of okadaic acid could be completely abrogated by a 2-h preincubation of cells with 0.5 µM staurosporine (Sigma), which is an inhibitor of a broad spectrum of kinases ( Figure 1A As hyperphosphorylation of Oct-2 upon inhibition of serine\ threonine-specific phosphatases may be a result of activation of cellular kinases which are regulated by phosphorylation itself, we next tested whether Oct-2 is phosphorylated on tyrosine residues. Treatment of the nuclear extracts from cells stimulated by okadaic acid with unspecific alkaline phosphatase ( Figure 1B , lane 2) as well as with serine\threonine-specific phosphatase PP1 (results not shown) effectively reduced the level of Oct-2 phosphorylation. In contrast, treatment of nuclear extracts with the tyrosinespecific phosphatase YOP ( Figure 1B, lane 3) did not alter the pattern of electrophoretic mobility of the Oct-2 species present in the extracts.
Interestingly, stimulation of HeLa or HEK 293 cells transiently transfected with Oct-2 expression construct pOEV1 by okadaic acid did not result in hyperphosphorylation of ectopically expressed Oct-2 protein (results not shown). Although the identity of the kinase or kinases involved in Oct-2 phosphorylation remains obscure, they are likely to be either specifically expressed in lymphoid cells or inactive in non-lymphoid cells under the conditions of the experiments.
Phosphorylation of Oct-2 differentially reduces protein binding to the non-canonical octamer sequence of the murine BLR1 gene promoter
We next tested whether phosphorylation of Oct-2 influences its ability to bind to the non-canonical octamer sites present in the human and murine BLR1 gene promoters. Both Oct-1 and Oct-2 factors bind to these motifs with a lower affinity than to the consensus octamer site (Figure 2) . Treatment of Raji cells with okadaic acid dramatically reduced the ability of Oct-2 and also of Oct-1 present in nuclear extracts from these cells to bind to the oligonucleotide mur-Oct, corresponding to the octamer site of the murine BLR1 promoter ( Figure 3A, lanes 1 and 2) . In contrast, incubation of the same nuclear extracts with the oligonucleotides corresponding to either the octamer sequence of the human BLR1 promoter (hum-Oct ; Figure 3A, lanes 3 and 4) or the consensus octamer sequence (Oct-wt ; Figure 3A , lanes 5 and 6) showed that Oct-2 binds to both these sites almost equally well as it does prior to hyperphosphorylation ( Figure 3B) , thus excluding the possibility that treatment of cells with okadaic acid reduces the amount of Oct-2 factor. In addition, immunoblotting analysis showed that treatment of Raji cells with okadaic acid does not significantly influence the amount of Oct-2 protein present in the nuclear extracts (see also Figure 1 ). At the same time Oct-1 binding to both oligonucleotides hum-Oct and Oct-wt was significantly reduced upon stimulation of cells by okadaic acid (Figure 3) . The specific impairment of Oct-2 binding to the octamer site of the murine BLR1 promoter could be efficiently prevented when the cells were incubated with 0.5 µM staurosporine for 2 h prior to the stimulation by okadaic acid (results not shown), providing additional evidence that the observed effect is due to the phosphorylation of this factor.
Okadaic acid blocks the expression of the BLR1 gene in murine splenocytes but not in human B cells
In the promoters of both human and murine BLR1 genes the non-canonical octamer site is an essential regulatory element and the binding of Oct-2 to this element plays a critical role in the regulation of promoter activity [20] . As described above, hyperphosphorylation of Oct-2 strongly reduces binding of this factor to the octamer site of the murine promoter but leaves the binding to the octamer site of the human gene promoter almost unaffected. It was interesting to test whether down-regulation of Oct-2 binding to the promoter sequence correlates with a downregulation of BLR1 gene expression. For this purpose mononuclear cell suspensions were prepared from spleens of Balb\c mice and incubated in culture with 100 ng\ml okadaic acid for 2, 4 and 8 h. In parallel, Raji cells or primary tonsillar mononuclear cells were treated with okadaic acid for the same periods of time. The steady-state levels of BLR1 mRNA isolated from these cell cultures were visualized by Northern-blot analysis using a cDNA probe of the human BLR1 gene. The amount of BLR1-specific mRNA was quantified by normalization with respect to GAPDH (glyceraldehyde-3-phosphate dehydrogenase) gene expression. As shown in Figure 4 , treatment of the murine cells with okadaic acid almost completely down-regulated the expression of the BLR1 gene, whereas the expression of this gene in cells of human origin was unaffected by stimulation with okadaic acid for up to 8 h.
To substantiate the assumption that down-regulation of Oct-2 binding to the murine BLR1 promoter results in the inactivation of its function, we tested further if okadaic acid affects the expression of the luciferase gene from the reporter construct containing the promoter of the murine BLR1 gene. For this purpose, Namalwa cells were transfected with the blr1-Luc luciferase reporter construct [20] , and were divided into three
Figure 5 Influence of okadaic acid treatment on the expression of luciferase from the blr1-Luc and blr1MH-Luc reporter constructs
Namalwa cells were transfected with blr1-Luc or blr1MH-Luc and incubated overnight, after which the cells were divided into three groups and reporter activity measured as indicated, either immediately (time point 0) or after incubation with or without okadaic acid for 7 h. The reporter activity at time point 0 was set to 1 in all experiments and the activity in cells incubated further is shown relative to this value. The bars represent the meanspS.D. of three independent experiments. equal parts after overnight incubation. One part was used to measure luciferase activity after overnight incubation, whereas the remaining two parts were further incubated for 7 hours, either in the presence of 100 ng\ml okadaic acid or in its absence. Subsequently, the cells were lysed and the reporter activity was measured. On average, the reporter activity in the cells incubated for an additional 7 h was increased by over 50 % compared with that after the overnight incubation ( Figure 5 ). However, no increase of luciferase expression was observed in cells incubated in the presence of okadaic acid. To test if this effect was due to the reduced binding of cellular Oct-2 protein to the recognition sequence in the promoter, we analysed in parallel the activity of the mutant reporter construct blr1MH-Luc. This construct differs from the blr1-Luc in a single nucleotide substitution, which was introduced into the Oct-2 binding site, changing its sequence to that of the human BLR1 promoter. In contrast with the situation described above, addition of okadaic acid to the incubation medium did not completely abort the expression of luciferase from this mutant construct, although the reporter activity in the transfected cells incubated in the presence of okadaic acid was reduced compared with that in the cells incubated for the same time without okadaic acid ( Figure 5) .
Localization of the phosphorylated residues in Oct-2 protein
Localization of the sites of phosphorylation could provide a hint regarding the candidate kinases involved in phosphorylation of Oct-2, because many kinases phosphorylate target proteins on serine or threonine residues located within specific amino acid sequences. In an attempt to identify the amino acid residues that become phosphorylated in Oct-2, a GST-Oct-2 fusion protein was expressed in E. coli and phosphorylated in itro with [γ-$#P]-labelled dATP using crude lysates of Raji cells pretreated in culture for 2 h with 100 ng\ml okadaic acid. After electrophoretic separation in a SDS\polyacrylamide (10 %) gel the proteins which incorporated radioactively labelled phosphates were detected by autoradiography ( Figure 6A ). Two major phosphorylated forms of the GST-Oct-2 fusion protein were detected in the gel. The molecular mass of the faster-migrating form appeared to correspond to that of the fusion protein prior to incubation with Raji cell lysates. The retarded form consisted of at least two separate bands that could be visualized by Coomassie Brilliant Blue staining of the gel. Both these bands produced a stronger radioactive signal than the faster-migrating form. These data suggest that phosphorylation of the GST-Oct-2 fusion protein causes a retardation of migration in SDS\polyacrylamide gels. Therefore phosphorylation of the recombinant fusion protein expressed in bacteria produces a similar effect to that observed with the native Oct-2 protein (compare to Figure 1A , lanes 1 and 2).
As a result of the proteolytic analysis of GST-Oct-2 fusion protein, five phosphorylated locations were identified within Oct-2 ( Figure 6B ). These include one peptide corresponding to the N-terminal part of the protein and four regions within the DNA-binding POU domain. Comparison of the identified phosphorylated peptide sequences with the database of the known preferred phosphorylation sites of different kinases [26] revealed two sites that match with the known patterns of phosphorylation. Both identified amino acid sequences lie within the POU-specific subdomain of Oct-2. They include the sequence Ser"*(-Asp-LeuGlu, which represents a preferred site of phosphorylation by casein kinase II (CK II), and the sequence Thr#!)-Phe-Lys, which is a potential site of phosphorylation by PKA.
DISCUSSION
Several lines of evidence suggest that phosphorylation of octamer factors may provide a mechanism of differential regulation of octamer factor binding to high-and low-affinity binding sites [14, 16] . Here we analysed the effect of hyperphosphorylation of Oct-2 induced by okadaic acid on binding of this factor to three octamer sequences. One is a classical high-affinity binding octamer site present in the promoters of immunoglobulin genes or in the H2B gene promoter [6] ; the other two are the noncanonical sequences identified in the promoters of the human and murine BLR1 genes [20] . The latter two differ from each other by a single nucleotide substitution at position 3 and both have a substitution at position 2 compared with the classical motif 5h-ATGCAAAT-3h. We showed that Oct-2 binds to the octamer site of the human BLR1 promoter with higher affinity than to its murine counterpart and with much lower affinity to both these sites compared with the classical octamer motif. The obtained data reveal that phosphorylation of Oct-2 causes a dramatic reduction of its ability to bind to the murine BLR1 non-canonical octamer sequence. At the same time, binding to the octamer sequence of the human BLR1 promoter or to the classical octamer site remained unaffected under the same conditions. The latter observation contradicts the previously described data showing inhibition of Oct-2 binding to the octamer site of the H2B promoter [16] . However, the opposite effects of the okadaic acid treatment of intact cells and inhibition of phosphatases in nuclear extracts may reflect the differential activation of kinases in i o and in itro.
The exact nature of the kinases involved in the process of Oct-2 phosphorylation could not be revealed in this study. Search for the sites of phosphorylation in Oct-2 protein identified four candidate locations within the POU domain, which mediates contact to the major groove of DNA and plays a critical role in the high-affinity sequence-specific binding [8] . Two of the four identified phosphorylated regions lie within the POU-specific subdomain directly contacting the 5h-ATGC subsite of the octamer motif [27] . We showed that the interaction of phosphorylated Oct-2 with DNA is sensitive to nucleotide substitutions within this subsite. The identified amino acid stretches within the POU-specific subdomain contain preferred sequences of phosphorylation by CK II and PKA. However, the direct involvement of these kinases in the process of Oct-2 phosphorylation was not proved in the present study. The effect of Oct-2 hyperphosphorylation upon treatment of cells with okadaic acid could not be prevented by a specific inhibitor of PKA. Additionally, the Ser"*( Ala or the Thr#!) Ala mutations of the CK II and PKA phosphorylation sites respectively were not able to abrogate inhibition of Oct-2 DNA binding caused by phosphorylation of this factor (results not shown). This suggests that the observed selective down-regulation of Oct-2 binding may be the result of the synergistic effect of phosphorylation of several amino acid residues.
A possible explanation for the observed effect of Oct-2 phosphorylation on binding-site recognition may be a direct electrostatic interference of the phosphates coupled to the protein domain responsible for DNA contact, therefore preventing effective binding. However, our results indicate that the inhibitory effect of Oct-2 phosphorylation specifically depends on the presence of a nucleotide other than G in position 3 of the octamer sequence. This suggests a probable alteration of Oct-2 factor conformation upon phosphorylation, which tenders this factor more restrictive to the nucleotide sequence of the recognition site compared with the unphosphorylated form of the protein. This scenario would resemble the effect of phosphorylation on the Pit-1 factor. Similar to Oct-2, phosphorylated Pit-1 exhibits a decreased binding affinity to selected binding sites and increased or unaltered binding to other recognition sites [14] . It was shown that the differential binding pattern of this factor is determined by a conformational change which leads to increased selectivity of the binding-site recognition dependent on the DNA sequences adjacent to the core motif.
The POU-specific domain is also responsible for proteinprotein interactions with co-activators of octamer factors. It was demonstrated that the B-cell-specific co-activator of octamerbinding factors termed Bob1 (OBF-1\OCA-B) [28] [29] [30] [31] [32] potentiates Oct-2-mediated activation of the BLR1 promoter and is essential for the expression of this gene [20] . Bob1 selectively interacts with the POU-specific domain and the POU-homeodomain of either Oct-1 or Oct-2, forming a ternary complex on the promoter DNA [33, 34] . In addition Bob1 is able to contact the major groove of DNA on its own although this interaction is stabilized only in the presence of a POU domain [35] . Association of Bob1 with the octamer factors increases the selectivity of the nucleotide-sequence recognition compared with the free octamer factors [33] .
One of the functions provided by the interaction of Bob1 with the POU domain is the stabilization of the POU-domain contacts on the DNA [34, 36] . The structural requirements for selective interaction between octamer factors and their co-activator Bob1 and formation of the ternary complex have been investigated recently [34] . Intriguingly, the residues in the POU domain that are essential for establishing contact with Bob1 were mapped to the very beginning of the first helix of the POU-specific domain, a region where two identified phosphorylation sites are located. Furthermore, it was shown that the presence of a guanine residue at position 3 of the octamer sequence is critical for the formation of the ternary complex with Bob1 [34] . As described above, the same nucleotide position determines the effect of Oct-2 phosphorylation on its binding ability. This raises the interesting possibility that phosphorylation of the POU-specific subdomain of Oct-2 may conditionally interfere with the interaction with the Bob1 co-activator. This would still enable sufficient contact between both proteins and DNA when the octamer sequence possesses a guanine residue at position 3. However, it would prevent interaction of proteins when this position is occupied by another nucleotide. As a result the contact of Oct-2 with the octamer site would no longer be stabilized by Bob1 and consequently the binding of this factor to DNA would be downregulated.
The expression of BLR1 on cultivated murine resting B cells or cell lines could be completely down-regulated upon stimulation by interleukin-6 or lipopolysaccharide [37] . Our data show that down-regulation of Oct-2 binding to the promoter of the murine BLR1 gene induced by hyperphosphorylation of this factor correlates with the dramatic reduction of the BLR1 mRNA level in murine splenic cells treated with okadaic acid. Therefore, phosphorylation of Oct-2 caused by activation of cellular kinases or inhibition of phosphatase activities may be one of the physiological mechanisms that mediates down-regulation of BLR1 gene expression in mice upon activation of B cells.
